Cargando…
NCAPG Is a Promising Therapeutic Target Across Different Tumor Types
BACKGROUND: With the advent of CRISPR-Cas9 genome editing tool in gene therapy, identification of aberrantly expressed genes is of great value across various cancer types. Since a large number of patients may benefit from molecular targeted gene therapy. The purpose of this study was to identify abe...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142249/ https://www.ncbi.nlm.nih.gov/pubmed/32300299 http://dx.doi.org/10.3389/fphar.2020.00387 |